Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)-Reference-Cited by-同舟云学术

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)

Published:2007-01 Issue:1 Volume:48 Page:65-71
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Medeiros Bruno C.,Minden Mark D.,Schuh Andre C.,Schimmer Aaron D.,Yee Karen,Lipton Jeff H.,Messner Hans A.,Gupta Vikas,Chun Kathy,Xu Wei,Das Prabodh,Kamel-Reid Suzanne,Brandwein Joseph M.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190601043252

Reference21 articles.

1. Acute Myeloid Leukemia

2. Long-term follow-up of cancer and leukemia group B studies in acute myeloid leukemia

3. The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC;Transplantation and Cellular Therapy;2023-06

2. Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective;PharmacoEconomics;2022-06-13

3. Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2021-09-07

4. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets;Blood Advances;2021-02-09

5. Very Late Relapse in Pediatric Acute Myeloid Leukemia: A Case Report and Brief Literature Review;Journal of Pediatric Hematology/Oncology;2020-10-30